One-Year study aims to uncover triggers of psychosis relapse in meth users
NCT ID NCT07459257
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study follows 150 people diagnosed with methamphetamine-induced psychotic disorder for one year. Researchers will track factors like medication adherence, social support, and insight into illness to see how they relate to changes in psychiatric symptoms. The goal is to better understand why some people relapse and others recover, which could improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could identify key factors that predict relapse or recovery in methamphetamine-induced psychosis, helping doctors tailor support and treatment.
What could go wrong
This is an observational study, not a treatment trial, so it won't test a new therapy. Results may not apply to all patients, and factors like adherence or social support can be hard to measure accurately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE INDUCED PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Elazığ Mental Health and Diseases Hospital
RECRUITINGElâzığ, Elâzığ, 23200, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••